| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Partner Fund Management | - | Yes | - | Detail |
| Casdin Capital | - | - | - | Detail |
| Cowen Group | - | - | - | Detail |
| Fidelity Biosciences | - | - | - | Detail |
| Nextech Invest | - | - | - | Detail |
| Perceptive Advisors | - | - | - | Detail |
| RA Capital Management | - | - | - | Detail |
| Redmile Group | - | - | - | Detail |
| Sabby Capital | - | - | - | Detail |
| Tavistock Life Sciences | - | - | - | Detail |
| Third Rock Ventures | - | - | - | Detail |
| Wellington Management | - | - | - | Detail |
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Apr 11, 2011 | Series A | $ 40M | F-Prime Capital,Third Rock Ventures | Detail |
| Jan 7, 2014 | Series B | $ 25M | Biotechnology Value Fund,Casdin Capital,etc. | Detail |
| Jan 1, 2012 | Series Unknown | 0 | Eight Roads Ventures | Detail |